| Literature DB >> 18687144 |
Joan M Hevel1, Laura C Olson-Buelow, Balasubramanian Ganesan, John R Stevens, Jared P Hardman, Ann E Aust.
Abstract
BACKGROUND: Although exposure to asbestos is now regulated, patients continue to be diagnosed with mesothelioma, asbestosis, fibrosis and lung carcinoma because of the long latent period between exposure and clinical disease. Asbestosis is observed in approximately 200,000 patients annually and asbestos-related deaths are estimated at 4,000 annually. Although advances have been made using single gene/gene product or pathway studies, the complexity of the response to asbestos and the many unanswered questions suggested the need for a systems biology approach. The objective of this study was to generate a comprehensive view of the transcriptional changes induced by crocidolite asbestos in A549 human lung epithelial cells.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18687144 PMCID: PMC2533023 DOI: 10.1186/1471-2164-9-376
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Volcano plot showing the magnitude of differential expression (log2 fold-change) compared to the measure of statistical significance (-log10 q-value). Color is on the density scale, so darker colors indicate over-plotting of points. Statistically significant genes are observed above the horizontal line, which corresponds to a q-value of 0.05. The low variability in the data caused a large number of genes (2,546) to be classified as statistically significant.
List of genes for which expression increased five-fold or greater or decreased two-fold or greater
| 115.7 | Early growth response 1 | |
| 38.3 | FOS | v-Fos FBJ murine osteosarcoma viral oncogene homolog |
| 25.3 | ATF3 | Activating transcription factor 3 |
| 19.5 | GTP binding protein overexpressed in skeletal muscle | |
| 17.1 | Nuclear receptor subfamily 4, group A, member 2 | |
| 16.6 | IL8 | Interleukin 8 |
| 15.9 | FST | Follistatin |
| 15.6 | PPP1R15A | Protein phosphatase 1, regulatory (inhibitor) subunit 15A |
| 13.7 | Stanniocalcin 1 | |
| 12.1 | v-Maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | |
| 11.2 | Chemokine (C-X-C motif) ligand 2 | |
| 10.4 | Tumor necrosis factor, alpha-induced protein 3 | |
| 9.4 | MAX dimerization protein 1 | |
| 9.1 | AT rich interactive domain 5B (MRF1-like) | |
| 9.0 | Nuclear receptor subfamily 4, group A, member 3 | |
| 8.6 | v-Jun sarcoma virus 17 oncogene homolog (avian) | |
| 7.8 | adult retina protein | |
| 7.4 | brain and reproductive organ-expressed (TNFRSF1A modulator) | |
| 7.2 | Multiple C2 domains, transmembrane 1 | |
| 7.2 | DNA-damage-inducible transcript 3 | |
| 7.2 | FBJ murine osteosarcoma viral oncogene homolog B | |
| 7.1 | GDF15 | Growth differentiation factor 15 |
| 6.9 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | |
| 6.9 | Dual specificity phosphatase 6 | |
| 6.6 | Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | |
| 6.5 | Interleukin 24 | |
| 6.3 | Sprouty homolog 2 (Drosophila) | |
| 6.1 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | |
| 6.0 | Kruppel-like factor 6 | |
| 6.0 | Interleukin 11 | |
| 5.6 | Interleukin-1 receptor-associated kinase 2 | |
| 5.5 | Interleukin 6 (interferon, beta 2) | |
| 5.5 | Histone 1, H4h | |
| 5.4 | folliculin interacting protein 1 | |
| 5.3 | Histone 2, H2be | |
| 5.2 | Myeloid cell leukemia sequence 1 (BCL2-related) | |
| 5.1 | Dual specificity phosphatase 10 | |
| 5.1 | Dehydrogenase/reductase (SDR family) member 2 | |
| 5.1 | Spectrin repeat containing, nuclear envelope 1 | |
| 5.1 | Hyaluronan synthase 2 | |
| 5.1 | period homolog 1 (Drosophila) | |
| 5.1 | zinc finger and BTB domain containing 10 | |
| -2.0 | Fibronectin 1 | |
| -2.0 | BCL2-like 11 (apoptosis facilitator) | |
| -2.0 | collagen, type V, alpha 1 | |
| -2.0 | vav 3 oncogene | |
| -2.0 | CSRP2 binding protein | |
| -2.0 | protease, serine, 23 | |
| -2.1 | Neuropilin 2 | |
| -2.1 | Death-associated protein kinase 1 | |
| -2.1 | Cadherin 1, type 1, E-cadherin (epithelial) | |
| -2.2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | |
| -2.2 | Ribonuclease, RNase A family, 4 | |
| -2.2 | Fibrinogen gamma chain | |
| -2.1 | Signal transducer and activator of transcription 4 | |
| -2.1 | Neurotrophic tyrosine kinase, receptor, type 3 | |
| -2.3 | Protocadherin 9 | |
| -2.2 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | |
| -2.2 | ST8SIA4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
| -2.3 | Mitogen-activated protein kinase kinase 6 | |
| -2.3 | latexin | |
| -2.3 | transmembrane 4 L six family member 20 | |
| -2.4 | Aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)///aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | |
| -2.7 | Solute carrier family 40 (iron-regulated transporter), member 1 |
A549 human lung epithelial cells were exposed to crocidolite asbestos at 6 g/cm2 for 24 h. Genes for which expression levels increased 5.0 fold or greater, or decreased 2.0 fold or greater, having q values less than 0.05 are shown. Probe sets associated with products of unknown function were not included. Bold-faced genes were not observed in the statistically upregulated expression profile of hydrogen-peroxide-treated A549 cells [36]. A list of all genes for which expression levels changed 2.0 fold or greater can be found as Additional File 2.
Figure 2Unsupervised hierarchical clustering analysis of A549 probe sets in which the expression was altered by crocidolite.(A) The main dendogram represents the intensity of each probe set in relation to the entire data set with green being low and red being high. Four major clusters of upregulated genes and two clusters of downregulated genes were observed and are shown as bracketed dendograms where the color represents the intensity of each probe set in relation to each specific cluster. (B) STRING analysis using the genes within the upregulated clusters demonstrated a functional relationship between 24 of the genes which encompassed cytokine, MAPkinase and JNK/SAPK signaling pathways.
Validation of the microarray data from crocidolite-treated human A549 cells
| Egr1 | 115.7 | 281.7 ± 3.8 | ||
| ATF3 | 25.3 | 23.7 ± 0.1 | ||
| c- | c-Jun | 8.6 | 10.5 ± 0.7 | |
| JunB | 2.2 | 3.6 ± 0.2 | ||
| Interleukin 8 | 16.6 | N.D. | Increased [ | |
| p53 | 1.8 | N.D. | Increased [ | |
| Mn-SOD | 2.2 | N.D. | Increased [ | |
| Heme oxygenase 1 | 2.1 | N.D. | Increased [ | |
| c- | myc | 2.0 | N.D. | Increased [ |
| p21, Cip1 | 1.9 | N.D. | Increased [ |
*represents significantly greater than control, q less than 0.05; N.D., not determined
† chrysotile-treated A549 human lung epithelial cells
‡ crocidolite-treated human pleural mesothelial cells
Figure 3Gene ontology analysis of the ( In (C) a global test to identify ontologies related to transcription was used to pinpoint significant functions. The p-values for each of the GO terms (abbreviated as the last four digits of each ontology's identifier) has been overlaid onto the hierarchical tree where the darkest gray node represents a p = 0.034 and the lightest represents a p = 0.017.
Figure 4Spatial depiction of the top scoring network and canonical pathways detected in crocidolite-treated A549 cells by Ingenuity Pathway The network was algorithmically generated based on the connectivity of each of the transcripts and the molecular interaction knowledge base. Each node represents a gene or gene product for which mRNA expression was upregulated (red) or downregulated (blue) in crocidolite-treated A549 cells. Edges/lines connecting the nodes represent molecular interactions between genes and/or gene products and are supported by at least one reference from the literature, a textbook, or from canonical pathway information stored in the Ingenuity Pathways Knowledge Base. The Nrf2-mediated oxidative stress canonical pathway identified by Pathway Analysis software shows differential upregulation of select genes within the cytoprotective arsenal.
Figure 5Pathway analysis of representative genes involved in the response of A549 cells exposed to crocidolite. In (A) the top five scoring networks were merged to create a cellular model consisting of ~150 genes for which expression levels changed ± 2-fold and demonstrated p-values less than 0.01. Nodes representing genes are colored red for upregulation or blue for downregulation and the intensity of the color reflects the degree of up- or downregulation. Lines connecting the nodes are indicators of interactions found in the knowledge database or current literature. In (B) and (C) the networks surrounding PTGS2, SMARCA4, and PTEN have been expanded for clarity. In (D) the relationship between E2F1 and TNF is observed.
Figure 6Asbestos induces a p53-mediated response in A549 lung cells. Experimental data is indicated by the thick blue edges and is discussed in more detail in the text. Known p53 targets which may have a role in the asbestos response and their biological effects are shown using thin gray lines. Nodes are color coded shades of red when expression levels increased and shades of blue when expression levels decreased. Nodes surrounded by dashed lines represent genes/gene products which were not represented on the gene chip but which displayed a functional relationship to queried nodes.